Diabetes Research Institute
Diabetes is one of the toughest challenges of our time in terms of public health. Ospedale San Raffaele, where diabetes is one of the central themes of research and assistance, in 2007 has gradually institutionalized and consolidated its commitment through the creation of the Diabetes Research Institute (DRI).
The DRI is an international center of excellence for the study, prevention and treatment of diabetes. This goal is pursued through a number of clinical programs in concert with research projects, often extended to the Institute’s internal and external collaborations, especially international.
View all the research and clinical groups here.
Among the many programs that exist within the DRI, some are of particular strategic importance. Examples are: transplantation of pancreatic islets and cell therapies for the induction of immunological tolerance, prevention of type 1 diabetes, modern technologies (eg. insulin pumps and artificial pancreas), study and prevention of diabetes complications and programs of cardio-diabetes and cardio-metabolism in type 2 diabetes. The final outcome of such research is the development of clinical studies to test new hypotheses for the cure of the disease (phase 1 and 2 studies) or improve current therapies (phase 3 studies).
Beta cell biology
Beta Cell Differentiation
Cardiodiabetes and core Lab
Cardiometabolism and clinical trials
Pier Marco Piatti
Complication of diabetes
Regulation of adaptive immunity
Senior physician, Pediatric diabetes Unit
Project leader, Pancreas Bioengineering
Research associate, Experimental diabetes
Group leader, Regulation of adaptive immunity Unit
Research associate, Transplant immunology
Research associate, Cardiodiabetes and core Lab
Pier Marco Piatti
Senior physician, Cardiometabolism and clinical trials Unit
Group leader, Beta cell biology Unit
Head physician, Transplant Medicine Unit
Project leader, Beta cell differentiation
Research associate, Complication of diabetes